Abstract

Noninvasive ultrasound surgery can be achieved using focused ultrasound to locally affect the targeted site without damaging intervening tissues. Mechanical ablation and histotripsy use short and intense acoustic pulses to destroy the tissue via a purely mechanical effect. Here, we show that coupled with low-frequency excitation, targeted microbubbles can serve as mechanical therapeutic warheads that trigger potent mechanical effects in tumors using focused ultrasound. Upon low frequency excitation (250 kHz and below), high amplitude microbubble oscillations occur at substantially lower pressures as compared to higher MHz ultrasonic frequencies. For example, inertial cavitation was initiated at a pressure of 75 kPa for a center frequency of 80 kHz. Low frequency insonation of targeted microbubbles was then used to achieve low energy tumor cell fractionation at pressures below a mechanical index of 1.9, and in accordance with the Food and Drug Administration guidelines. We demonstrate these capabilities in vitro and in vivo. In cell cultures, cell viability was reduced to 16% at a peak negative pressure of 800 kPa at the 250 kHz frequency (mechanical index of 1.6) and to 10% at a peak negative pressure of 250 kPa at a frequency of 80 kHz (mechanical index of 0.9). Following an intratumoral injection of targeted microbubbles into tumor-bearing mice, and coupled with low frequency ultrasound application, significant tumor debulking and cancer cell death was observed. Our findings suggest that reducing the center frequency enhances microbubble-mediated mechanical ablation; thus, this technology provides a unique theranostic platform for safe low energy tumor fractionation, while reducing off-target effects.

Highlights

  • The National Cancer Institute estimates that 1.8 million new cases of cancer will be diagnosed in the USA in 2020 and over 600,000 patients will die from the disease.[1]

  • MB expansion ratio was predicted through numerical simulations, for peak negative pressures (PNP) ranging from 0 to 500 kPa, and for center frequencies of 2 MHz, 250 kHz, and 80 kHz

  • Our focus here is on mechanical tumor fractionation via histotripsy, where our aim is to reduce the required energy for standard histotripsy by over an order of magnitude through the use of targeted MBs (TMB) coupled with low frequency US

Read more

Summary

Introduction

The National Cancer Institute estimates that 1.8 million new cases of cancer will be diagnosed in the USA in 2020 and over 600,000 patients will die from the disease.[1] Breast cancer is the most common solid tumor in women, accounting for more than 25% of all cancer-related deaths.[1] Surgical resection is the most frequently selected intervention, because minimization of cancerous tissues renders immunotherapies and chemotherapies more effective.[2] Nevertheless, surgery is an invasive procedure that carries a risk for the patient; thus, alternative noninvasive surgical techniques are greatly needed. Among these techniques, focused ultrasound (FUS) is a versatile, noninvasive, clinically adopted therapy method.[3] Compared to other ablation techniques such as radiofrequency ablation,[4] microwave ablation,[5] laser ablation,[6] and cryosurgery,[7] ultrasound (US) is noninvasive and cost-effective and offers a high penetration depth.[8] Conversely, low frequency FUS (below

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call